Difficulty: Medium
Average Score: 65%
Practice
Which of the following is a non-steroidal antiandrogen that is palliative in advanced carcinoma prostate when combined with a GnRH agonist:
Correct answer
D
Rationale
The correct answer is D: Flutamide. Flutamide is a non-steroidal antiandrogen used in advanced prostate carcinoma. It works by blocking androgen receptors in the prostate, thereby inhibiting the growth of prostate cancer cells. When combined with a GnRH agonist, it helps reduce testosterone levels further, providing palliative treatment for advanced prostate cancer.
A: Cyproterone acetate is another antiandrogen, but it is a steroidal one and not commonly used for this purpose.
B: Danazol is not typically used in the treatment of advanced prostate carcinoma.
C: Finasteride is a 5-alpha reductase inhibitor used for benign prostatic hyperplasia and male pattern baldness, not for advanced prostate cancer.
A: Cyproterone acetate is another antiandrogen, but it is a steroidal one and not commonly used for this purpose.
B: Danazol is not typically used in the treatment of advanced prostate carcinoma.
C: Finasteride is a 5-alpha reductase inhibitor used for benign prostatic hyperplasia and male pattern baldness, not for advanced prostate cancer.